Attention deficit hyperactivity disorder (ADHD) is a condition characterised by concentration difficulties and short attention span and/or hyperactivity and impulsiveness. ADHD medicines are various active substances that are distinguished by their effect duration. Among other things, the medicines affect the neurotransmitters dopamine and noradrenalin. The prescription of ADHD medicines should be accompanied by a thorough assessment and support. The Swiss Atlas of Healthcare shows ADHD medicines dispensed by outpatient care providers to children and adolescents, to adults, and in total. The underlying data sources only comprise care and treatments covered by the compulsory health insurance. Those covered by invalidity insurance (IV) are not included. With regard to the dispensing of medication in the inpatient sector, no comprehensive data is available. When interpreting the indicator, it should be noted that psychiatric care in Latin-speaking Switzerland focuses more on outpatient services, while inpatient care in psychiatric clinics and psychiatric departments of general hospitals is more important in German-speaking Switzerland (see also Obsan-Bulletin 03/2024).